Sovihep v Tab

Hepatitis

Description
Shipping Options
Customer Reviews

SOVIHEP-V is a fixed-dose combination antiviral medication containing Sofosbuvir (400 mg) + Velpatasvir (100 mg). It is used to treat chronic hepatitis C virus (HCV) infection in adults, offering a high cure rate across multiple HCV genotypes.

Composition

Active Ingredients:
- Sofosbuvir (400 mg) – HCV NS5B polymerase inhibitor.
- Velpatasvir (100 mg) – HCV NS5A replication complex inhibitor.
Inactive Ingredients:
- Microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide.

Mechanism of Action

Sofosbuvir: Blocks HCV RNA replication by inhibiting the NS5B polymerase.
Velpatasvir: Prevents viral assembly by targeting the NS5A protein.
Combined effect: Highly effective in suppressing HCV replication, leading to sustained virologic response (SVR).

Dosage & Administration

Standard Dose: 1 tablet (400/100 mg) once daily, taken with or without food.
Treatment Duration:
- 12 weeks for most genotypes (1-6).
- 24 weeks for cirrhotic patients with genotype 3.
Missed Dose: Take as soon as remembered, but skip if close to the next dose.

Uses

Chronic HCV Infection (Genotypes 1-6).
Compensated Cirrhosis (with or without HIV co-infection).
Post-Liver Transplant HCV Recurrence.

Storage

Store below 30°C in a dry place.
Keep in original packaging (protects from moisture).

Recommendations

Take consistently at the same time daily.
Avoid proton pump inhibitors (PPIs) – Take 4 hours apart if needed.
Monitor liver function tests (LFTs) during treatment.

Important Notes

Side Effects

Common: Fatigue, headache, nausea.
Rare: Bradycardia (if taken with amiodarone), anemia.

Contraindications

Concurrent use with rifampin or St. John’s wort (reduces efficacy).
Severe liver impairment (Child-Pugh C) – Use with caution.

Drug Interactions

Antacids/PPIs: Reduce velpatasvir absorption.
Amiodarone: Risk of severe bradycardia.

Achieves >95% cure rate in most patients.

Composition

Active Ingredients:
- Sofosbuvir (400 mg) – HCV NS5B polymerase inhibitor.
- Velpatasvir (100 mg) – HCV NS5A replication complex inhibitor.
Inactive Ingredients:
- Microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide.

Mechanism of Action

Sofosbuvir: Blocks HCV RNA replication by inhibiting the NS5B polymerase.
Velpatasvir: Prevents viral assembly by targeting the NS5A protein.
Combined effect: Highly effective in suppressing HCV replication, leading to sustained virologic response (SVR).

Dosage & Administration

Standard Dose: 1 tablet (400/100 mg) once daily, taken with or without food.
Treatment Duration:
- 12 weeks for most genotypes (1-6).
- 24 weeks for cirrhotic patients with genotype 3.
Missed Dose: Take as soon as remembered, but skip if close to the next dose.

Uses

Chronic HCV Infection (Genotypes 1-6).
Compensated Cirrhosis (with or without HIV co-infection).
Post-Liver Transplant HCV Recurrence.

Storage

Store below 30°C in a dry place.
Keep in original packaging (protects from moisture).

Recommendations

Take consistently at the same time daily.
Avoid proton pump inhibitors (PPIs) – Take 4 hours apart if needed.
Monitor liver function tests (LFTs) during treatment.

Important Notes

Side Effects

Common: Fatigue, headache, nausea.
Rare: Bradycardia (if taken with amiodarone), anemia.

Contraindications

Concurrent use with rifampin or St. John’s wort (reduces efficacy).
Severe liver impairment (Child-Pugh C) – Use with caution.

Drug Interactions

Antacids/PPIs: Reduce velpatasvir absorption.
Amiodarone: Risk of severe bradycardia.

Achieves >95% cure rate in most patients.

Shipping Options –

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions –

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Description
Reviews (0)

Composition

Active Ingredients:
- Sofosbuvir (400 mg) – HCV NS5B polymerase inhibitor.
- Velpatasvir (100 mg) – HCV NS5A replication complex inhibitor.
Inactive Ingredients:
- Microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide.

Mechanism of Action

Sofosbuvir: Blocks HCV RNA replication by inhibiting the NS5B polymerase.
Velpatasvir: Prevents viral assembly by targeting the NS5A protein.
Combined effect: Highly effective in suppressing HCV replication, leading to sustained virologic response (SVR).

Dosage & Administration

Standard Dose: 1 tablet (400/100 mg) once daily, taken with or without food.
Treatment Duration:
- 12 weeks for most genotypes (1-6).
- 24 weeks for cirrhotic patients with genotype 3.
Missed Dose: Take as soon as remembered, but skip if close to the next dose.

Uses

Chronic HCV Infection (Genotypes 1-6).
Compensated Cirrhosis (with or without HIV co-infection).
Post-Liver Transplant HCV Recurrence.

Storage

Store below 30°C in a dry place.
Keep in original packaging (protects from moisture).

Recommendations

Take consistently at the same time daily.
Avoid proton pump inhibitors (PPIs) – Take 4 hours apart if needed.
Monitor liver function tests (LFTs) during treatment.

Important Notes

Side Effects

Common: Fatigue, headache, nausea.
Rare: Bradycardia (if taken with amiodarone), anemia.

Contraindications

Concurrent use with rifampin or St. John’s wort (reduces efficacy).
Severe liver impairment (Child-Pugh C) – Use with caution.

Drug Interactions

Antacids/PPIs: Reduce velpatasvir absorption.
Amiodarone: Risk of severe bradycardia.

Achieves >95% cure rate in most patients.

Reviews

There are no reviews yet.

Be the first to review “Sovihep v Tab”

Description
Reviews (0)

Composition

Active Ingredients:
- Sofosbuvir (400 mg) – HCV NS5B polymerase inhibitor.
- Velpatasvir (100 mg) – HCV NS5A replication complex inhibitor.
Inactive Ingredients:
- Microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide.

Mechanism of Action

Sofosbuvir: Blocks HCV RNA replication by inhibiting the NS5B polymerase.
Velpatasvir: Prevents viral assembly by targeting the NS5A protein.
Combined effect: Highly effective in suppressing HCV replication, leading to sustained virologic response (SVR).

Dosage & Administration

Standard Dose: 1 tablet (400/100 mg) once daily, taken with or without food.
Treatment Duration:
- 12 weeks for most genotypes (1-6).
- 24 weeks for cirrhotic patients with genotype 3.
Missed Dose: Take as soon as remembered, but skip if close to the next dose.

Uses

Chronic HCV Infection (Genotypes 1-6).
Compensated Cirrhosis (with or without HIV co-infection).
Post-Liver Transplant HCV Recurrence.

Storage

Store below 30°C in a dry place.
Keep in original packaging (protects from moisture).

Recommendations

Take consistently at the same time daily.
Avoid proton pump inhibitors (PPIs) – Take 4 hours apart if needed.
Monitor liver function tests (LFTs) during treatment.

Important Notes

Side Effects

Common: Fatigue, headache, nausea.
Rare: Bradycardia (if taken with amiodarone), anemia.

Contraindications

Concurrent use with rifampin or St. John’s wort (reduces efficacy).
Severe liver impairment (Child-Pugh C) – Use with caution.

Drug Interactions

Antacids/PPIs: Reduce velpatasvir absorption.
Amiodarone: Risk of severe bradycardia.

Achieves >95% cure rate in most patients.

Reviews

There are no reviews yet.

Be the first to review “Sovihep v Tab”

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.